-
Study aim
-
Examination of the Effect of Nigella Sativa Oil in the Prevention of Chemotherapy-Induced Phlebitis
-
Design
-
This clinical trial was conducted with a control group at Tohid Hospital in Sanandaj. 60 Patients with Gastric cancer (Colon, Rectum, Esophagus, stomach) undergoing chemotherapy were selected based on the inclusion criteria by convenience sampling. Then, Research units based on simple randomization method (Lottery Cards) were placed in intervention (30) and control group (30).
-
Settings and conduct
-
Tohid Hospital of Sanandaj
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Consciousness, Age between 25-75 years, Patients with Gastrointestinal cancers (colon, rectum, esophagus, stomach), Hospitalized in the Oncology Ward of Tohid Hospital, Without fever & neutropenia.
Exclusion criteria: Unwillingness to be in the study, Worsen the condition of patient, Incidence of allergic reactions.
-
Intervention groups
-
The first group, included patients in the intervention group, who received intervention with Nigella Sativa oil and the second group, included patients in the control group who received no intervention. Intervention group: after insertion of IV catheter with aseptic technique, 5 drops of Nigella Sativa oil (prepared by the pharmacist) was applied around the area of intravenous chemotherapy injection, every 12 hours (morning and night before sleep), from the first day of chemotherapy up to third day. In addition, each time before using of the oil, the place was rinsed with water. Control group: no intervention was done, only the area of the catheter was assessed for any sign of phlebitis. Then, two groups were evaluated every 12 hours over 72 hours for assessing the incidence and severity of phlebitis. The Phlebitis Visual Scale was used to assess the incidence and severity of phlebitis.
-
Main outcome variables
-
Phlebitis